SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: KELLIS who wrote (3233)8/30/1997 1:41:00 PM
From: Tokyo VD   of 3991
 
I don't know the specifics. Management is headed to Boston and New York this week after Denver last week. Lee Wilson is on the road with Nina.

They are playing the news close to the vest, but indicate that it is significant. I've been hearing this from institutional holders invested in the stock (remember, Tudor Fund is in Boston and is one of the biggest holders, no. 3 I believe).

My guess is that it is either U.K. approval or the achievement of getting its own ICD-9 code for the product. This may make insurance approval easier.

Unfortunately, I've also been told that the NJ plant has not been reinspected. This doesn't bode well for the timeliness of scheduling the inspection of the additional lines. This is all I know. Best of luck. Remember, there are no short term negatives in the stock so most likely it will draft upwards with the other small cap stocks...

Good luck to all.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext